Cancer accounts for 33% of Years of Life Lost <75y in England More than circulatory, liver, respiratory conditions & diabetes combined! 😮 ⁦CanTest⁩ ⁦Richard Roope 💙⁩

Our own Dr Sam Merriel 💙💛 CanTest UoM Primary Care talking about #early #detection of #prostate #cancer & his hugely impactful & important Cancer Research UK PhD work william hamilton University of Exeter

Early detection and diagnosis are key to improving outcomes, and primary care is central to this. Today, I spoke at the summit of our CANTEST Collaborative about our new strategy, and our vision for primary care detection moving forward.

A fantastic overview of cervical screening, investigation and treatment techniques over the years by Peter Sasieni CanTest cancer detection summit.

Wonderful romp through innovative devices offering hope for #cervical #cancer #screening from Peter Sasieni @CancerPrev_KCL CanTest Cancer Early Detection Summit. So exciting to see how we can make new strides towards eliminating this devastating disease! #screeningsaveslives

Great first day of the CanTest summit today. Fantastic to see the progress in research into early cancer diagnosis in primary care. Still plenty to do, including unpacking the different functions of safety netting, as explained by Dr Georgia Black in today’s final session.

Gearing up for our second day of the CanTest Primary Care Cancer Detection Summit - today we're looking to the future and exploring opportunities for improving cancer detection and diagnosis. Can't wait to hear from our visionary speakers!

Great to hear Kate Brain providing an overview of patient access CanTest summit. Lots of work still to do but silver linings are there! Cancer Research UK Royal College of General Practitioners PRIME Centre Wales Wales Cancer Research Centre DPM

Looking forward to another great day of talks at the #CanTestSummit showcasing the amazing achievements in early cancer detection research in primary care over the last 5 years and future goals! CanTest

Eye opening talk by YoryosLyratzopoulos at the #CanTestSummit summarising research advances in cancer risk assessment since the 2015 NICE guidelines and where future research should be focusing! CanTest

Grateful for CanTest for letting me explain why early cancer diagnoses matter Wellcome Collection in London. We covered the opportunities from UK hyperaccelerated studies and new research landscape. 🇬🇧

Really interesting to hear about women’s preferences for tests for #ovarian #cancer from ⁦@bethshinkins⁩ ⁦CanTest⁩ Summit. So important to know what women want when innovating in this area ⁦Fiona Walter⁩ ⁦william hamilton⁩ ⁦Garth Funston⁩

#CanTestSummit Panel discussing how we need to increase GP direct access to radiological tests to improve early cancer detection! william hamilton YoryosLyratzopoulos @bethshinkins Dr Lennard Lee (Oxford University) CanTest

Prof ⁦Suzanne Scott⁩ talks about barriers to equitable access to cancer diagnosis ⁦CanTest⁩

🏥🚨‼️between 1 in 4 and 1 in 3 cancer patients are diagnosed via emergency departments across Canada🇨🇦, Australia🇦🇺, the UK🇬🇧 and Denmark🇩🇰. This is associate with ⬆️ mortality and needs to be reduced. YoryosLyratzopoulos presenting #ICBP findings at #CanTestSummit CanTest

Prof Larry Kessler presenting on the promise and the uncertainty of multi-cancer early detection tests ⁦Multicancer Early Detection (MCED) Consortium⁩ ⁦CanTest⁩

📱 What could the future hold? Prof Matthew Thompson summarising how wearables and smartphones could be used in early cancer detection 🦠 CanTest #CanTestSummit

Emma Crosbie Peter Sasieni expertly chairing the session on early cancer detection research directions session with a fantastic session opening talk CanTest cancer detection summit 2022 #primarycare #cancer #earlydetection Wellcome Collection Team Womb

Enjoying great talks at the CanTest Primary Care Cancer Detection Summit! Pereira/Acedo Lab is looking forward to starting the newly Cancer Research UK funded project 👏🏻

Witnessing a fantastic talk by Peter Johnson CanTest in London talking about how innovation and research can deliver much better cancer outcomes in England.